Browse studies, page 398
Page 398 of 1,298, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Effectiveness of doubling the daily dose of Proton pump inhibitors in Preventing Stress Ulcer Bleeding in Perioperative Patients with Risk Factors: A Propensity Score - Matched Cohort Study 2025
- Gastroprotective action of Piper aduncum L. leaf essential oil mediated by α2-adrenergic biochemical pathways, nitric oxide synthase, and sulfhydryl compounds Journal of ethnopharmacology, 2026
- Exploring Causal Links Among Proton Pump Inhibitors, Gut Microbiota and Ischemic Stroke: A Mediation Mendelian Randomization Study 2025
- Evaluation of diagnostic tests for suspected hypersensitivity reactions to proton pump inhibitors in children Allergy and asthma proceedings, 2025
- Association between proton pump inhibitor use and muscle mass: a US population-based study Aging clinical and experimental research, 2026
- Bioequivalence of two rabeprazole formulations and pharmacokinetic variability by CYP2C19 genotype and sex in healthy Korean participants: A four-period replicated crossover study Clinical pharmacology in drug development, 2026
- Effects of Vonoprazan on Isolated Rat Lower Esophageal Sphincter and Ileum Pharmaceuticals (Basel, Switzerland), 2026
- Multianalytical and Theoretical Tendency for the Clarification of the Binding of Lansoprazole and Albumin Protein ACS omega, 2026
- CYP2C19 genetic polymorphisms and proton pump inhibitor therapy resistance in patients with gastrooesophageal reflux disease: a preliminary observational cohort study Drug metabolism and personalized therapy, 2026
- Real-world pharmacological treatment of patients with hyperemesis gravidarum in 9 cities of China from 2019 to 2024: a cross-sectional analysis Frontiers in pharmacology, 2026
- Pharmacokinetics of CYP2C19- and CYP3A4-Metabolized Drugs in Cirrhosis Using a Whole-Body PBPK Approach Pharmaceutics, 2025
- Trends, utilisation and appropriateness of proton pump inhibitor prescriptions among recent initiators: a decade-long analysis of patients with a 1-year washout period (2013-2021) BMJ open, 2026
- Position-Specific Carbon Isotope Fingerprinting of Fluorinated Organics and Degradation Products Analytical chemistry, 2026
- Immediate reactions to proton pump inhibitors: Clinical findings and testing outcomes Allergologia et immunopathologia, 2025
- Proton pump inhibitors and the risk of urolithiasis: A Mendelian randomization study Medicine, 2025
- Efficacy of Vonoprazan in Nonsteroidal Anti-Inflammatory Drug-Induced Ulcer in Terms of Ulcer Recurrence and Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis Gastroenterology research and practice, 2025
- Drug Utilization Pattern of Proton Pump Inhibitors in Patients with Acid Peptic Disease and Comorbidities in India: A Real-World Electronic Medical Records-Based Study Drugs - real world outcomes, 2026
- Vonoprazan in erosive esophagitis: Influence of gender and hiatus hernia on outcomes Pakistan journal of medical sciences, 2026
- Single-cell-level digital twins for preterm birth prevention strategies 2025
- Pharmacogenetic phenoconversion modeling of drug–drug–gene interactions on CYP2C19 activity: effects of comedication by genotype on escitalopram concentrations 2026
- Vonoprazan-tetracycline dual regimen as rescue therapy for Helicobacter pylori infection: randomized controlled trial Gastroenterology, 2026
- Integrative pharmacovigilance and AI-based framework uncovers potential drug triggers in juvenile idiopathic arthritis Frontiers in immunology, 2025
- Association between Gastric Acid Suppression Therapy and Scattered White Spots in the Duodenum: A Retrospective Observational Study Endoscopy international open, 2026
- Severe Combined Vitamin B12 and Folate Deficiency Presenting With Features Suggestive of Hemolytic Anemia in Two Long-Term Proton Pump Inhibitor Users: A Case Report Cureus, 2026
- Fourteen-day vonoprazan-based dual therapy with amoxicillin as first-line Helicobacter pylori treatment in comparison with sequential therapy: A randomized controlled trial Journal of the Formosan Medical Association = Taiwan yi zhi, 2026
- Comparing the Interactions of Trichomonas vaginalis/gallinae Legumain-Like Cysteine Protease 1 (LEGU-1) and Human Legumain (LGMN) Protein Sequences with Proton Pump Inhibitor Drugs (Lansoprazole, Omeprazole, and Esomeprazole) by Bioinformatics Analyses Acta parasitologica, 2025
- Effect of Probiotics and Therapeutic Additives on the Osmolality of Pasteurized Donor Human Milk Cureus, 2026
- Vonoprazan attenuates proteinuria in diabetic kidney disease through potential direct renal mechanism Scientific reports, 2025
- Impact of Proton Pump Inhibitors on Blood Glucose in Type 2 Diabetes: A Systematic Review with Meta-analysis Journal of mid-life health, 2026
- Homochiral Metal-organic Framework (+)-diacetyl-L-tartaric-NH-MIL-101(Fe) as Stationary Phase for Enantioseparation in Capillary Electrochromatography Journal of separation science, 2026
- Enantioseparation of proton pump inhibitors using multimodal chiral cation exchangers Analytical and bioanalytical chemistry, 2026
- Impact of P-glycoprotein substrates on transendothelial transport of amyloid-β peptide in an in vitro model Neuroscience, 2026
- The Efficacy of Keveprazan, Vonoprazan, and Lansoprazole for the Treatment of Gastroesophageal Reflux Disease: A Network Meta-Analysis Current topics in medicinal chemistry, 2026
- Association of Long-Term Proton Pump Inhibitor Use With Nutrient Deficiencies: A Retrospective Cross-Sectional Study Cureus, 2026
- Integrating Single-cell and Machine Learning with Experimental Validation Reveals FASN Conferring Breast Cancer Stem cell-like Properties: Therapeutic Insights and Prognostic Implications Research Square, 2025
- Dose and duration shape the efficacy of vonoprazan versus lansoprazole for erosive esophagitis: insights from meta-regression Therapeutic advances in gastroenterology, 2025
- Hypersensitivity reactions with proton pump inhibitors: five years of clinical experience Allergologia et immunopathologia, 2026
- Stability of proton pump inhibitors for use in hypersensitivity evaluation The journal of allergy and clinical immunology. Global, 2026
- Online monitoring of catechin compounds transformation by the stationary phase of star phenylalanine cyclodextrin polymer Journal of chromatography. A, 2026
- Virtual internal exposures of lansoprazole administered to cytochrome P450 2C19 poor metabolizers estimated by simplified physiologically based pharmacokinetic modeling The Journal of toxicological sciences, 2026
- Lansoprazole Improves Long-Term Neurological Function via Alleviating Intestinal Injury in a Mouse Model of Intracerebral Hemorrhage Journal of visualized experiments : JoVE, 2026
- Levofloxacin versus moxifloxacin in nitazoxanide-based quadruple therapy as a first- and second-line treatment for Helicobacter pylori infection: NILE, a randomized, comparative, multicenter study 2025
- Integrating Clinical Evidence with PBPK Modeling to Assess PPI-Clopidogrel-CYP2C19 Interactions in Chinese ACS Patients Pharmaceutical research, 2026
- Genetic causal association between kidney stones and proton pump inhibitors International urology and nephrology, 2026
- Proton Pump Inhibitors and Cardiac Safety: Emerging Evidence Linking Cardiovascular Disease, Arrhythmias, and Mechanistic Pathways 2025
- Design of immediate release combination preparation containing alkalizer and lansoprazole for mechanistic understanding of enhanced gastric stability, pharmacokinetics, and intragastric pH variability in healthy human subjects International journal of pharmaceutics: X, 2026
- Considerations for environmental sustainability in clinical trials: A case study simulation of the REVISE trial Journal of critical care, 2026
- Chemical constituents and anti-ulcer effects of a wild pear (Pyrus syriaca Boiss.): Phytochemical, histopathological and apoptotic approaches PloS one, 2026
- Rabeprazole exhibits broad-spectrum fusion inhibition against Nipah pseudovirus and authentic HCoV-OC43 and RSV. Bioorganic chemistry, 2026
- Quantification of oxaliplatin and lansoprazole in tumor tissue homogenates by LC-MS/MS: a fit-for-purpose bioanalytical approach Bioanalysis, 2026
- Lansoprazole Enhances Everolimus Efficacy Through DDIT3 ‐Mediated PI3K / AKT /mTOR Pathway Inhibition in Pancreatic Neuroendocrine Neoplasms Proliferation FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026
- Lansoprazole/β-Cyclodextrin-Based Metal-Organic Frameworks: Development, Characterization, and Anti-Ulcer Activity Evaluation on Rats Current drug delivery, 2026
- Lansoprazole as a possible trigger of restless legs syndrome with suspected periodic limb movement disorder in a hemodialysis patient: a case report CEN case reports, 2026
- A lansoprazole-like structure derived from Streptomyces metabolites: evaluation of its protective effects on hepatorenal function, antioxidant activity, and immune parameters in African catfish challenged with Staphylococcus aureus Fish physiology and biochemistry, 2026
- QSPR modelling of PPI drugs using hybrid topological indices Frontiers in chemistry, 2026
- A Case Report of Hematemesis in a 4-Week-Old Neonate: Clinical Reasoning and Outcome After Empiric Acid Suppression Case reports in pediatrics, 2026
- Efficacy and Safety of Lansoprazole in Patients with Low to Moderate Bleeding Risk Undergoing Percutaneous Coronary Intervention 2025
- Comparative effectiveness and safety of proton pump inhibitors after myocardial infarction on dual antiplatelet therapy: Insights from a target trial emulation British journal of clinical pharmacology, 2026
- Lansoprazole-Induced Microscopic Colitis Mimicking Anticancer Drug-Related Diarrhea During Lenvatinib and Pembrolizumab Combination Therapy: A Case Report Clinical case reports, 2026
- Repurposing of lansoprazole and nitazoxanide as NR2F2 inhibitors in the gastric cancer cell line GCIY: computational insights and siRNA-mediated in vitro tests Frontiers in chemistry, 2026
- Effect of High-Fat Meal on the Pharmacokinetics and Safety of Lansoprazole Enteric-Coated Capsules in Healthy Chinese Subjects Clinical pharmacology in drug development, 2026
- Lansoprazole incorporated β-chitin-lyophilised PRF composite hydrogel for treatment of gastric ulcer Journal of materials science. Materials in medicine, 2026
- Persistent Choking Sensation After Aortic Valve Replacement: A Case Report 2026
- Tragopogon coelesyriacus Boiss. attenuates ethanol-induced gastric ulcer in vivo: modulation of oxidative stress, inflammation, and apoptosis PloS one, 2026
- Non-genetic factors play more important role in lansoprazole metabolism than CYP2C19 pharmacogenetic profiles in European patients with burns Research Square, 2026
- Relaxant effect of omeprazole and lansoprazole in guinea pig gallbladder muscle strips in vitro Journal of gastroenterology, 2003
- A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis. Multicentre Investigational Group Alimentary pharmacology & therapeutics, 1995
- Lansoprazol ++ : a new proton pump inhibitor Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 1998
- Enantioselective disposition of omeprazole, pantoprazole, and lansoprazole in a same Brazilian subjects group Chirality, 2012
- Lansoprazole-associated collagenous colitis: a case report Zeitschrift fur Gastroenterologie, 2005
- The effect of food and antacids on lansoprazole absorption and disposition European journal of drug metabolism and pharmacokinetics, 1991
- Acid-inhibitory effects of omeprazole and lansoprazole in Helicobacter pylori-negative healthy subjects Alimentary pharmacology & therapeutics, 1998
- Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori Journal of clinical gastroenterology, 1995
- The effect of itopride combined with lansoprazole in patients with laryngopharyngeal reflux disease European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2013
- Application of nanoparticles for oral delivery of acid-labile lansoprazole in the treatment of gastric ulcer: in vitro and in vivo evaluations International journal of nanomedicine, 2015
- Lansoprazole: a comprehensive review Pharmacotherapy, 1997
- Randomized study of lafutidine vs lansoprazole in patients with mild gastroesophageal reflux disease World journal of gastroenterology, 2016
- Twenty-four-hour monitoring of intragastric acidity: comparison between lansoprazole 30mg and pantoprazole 40mg European journal of gastroenterology & hepatology, 1997
- Lansoprazole increases testosterone metabolism and clearance in male Sprague-Dawley rats: implications for Leydig cell carcinogenesis Toxicology and applied pharmacology, 2003
- Inappropriate proton pump inhibitor lansoprazole prescription in older adults hospitalized in long-term care unit Irish journal of medical science, 2023
- Lansoprazole: a review of its role in Helicobacter pylori eradication therapy Revista espanola de enfermedades digestivas, 1999
- Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: inhibition of growth is not related to inhibition of urease Antimicrobial agents and chemotherapy, 1995
- Safety of lansoprazole in the treatment of gastroesophageal reflux disease in children Journal of pediatric gastroenterology and nutrition, 2002
- Quality evaluation of extemporaneous delayed-release liquid formulations of lansoprazole American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2011
- Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial Italian journal of gastroenterology and hepatology, 1997
- Mechanism of CRM1 Inhibition by Lansoprazole and Its Synergy with Cisplatin in Gastric Cancer Journal of medicinal chemistry, 2026
- Evaluation of the pharmacokinetics and pharmacodynamics of intravenous lansoprazole Alimentary pharmacology & therapeutics, 2004
- Pharmacokinetic interaction between lansoprazole and theophylline Therapeutic drug monitoring, 1995
- Comparative study of esomeprazole and lansoprazole in triple therapy for eradication of Helicobacter pylori in Japan World journal of gastroenterology, 2014
- Pharmacokinetics and Pharmacodynamics of Lansoprazole/Sodium Bicarbonate Immediate-release Capsules in Healthy Chinese Subjects: An Open, Randomized, Controlled, Crossover, Single-, and Multiple-dose Trial Clinical pharmacology in drug development, 2023
- Effect of lansoprazole on Helicobacter pylori Clinical therapeutics, 1993
- Pharmacokinetic interaction between acetaminophen and lansoprazole Journal of clinical gastroenterology, 1999
- Lansoprazole is an antituberculous prodrug targeting cytochrome bc1 Nature communications, 2015
- Stability of suspension formulations of lansoprazole and omeprazole stored in amber-colored plastic oral syringes The Annals of pharmacotherapy, 2000
- Lansoprazole Upregulates Polyubiquitination of the TNF Receptor-Associated Factor 6 and Facilitates Runx2-mediated Osteoblastogenesis EBioMedicine, 2015
- Comparison of lansoprazole and omeprazole in the short-term management of duodenal ulcers in Taiwan Journal of gastroenterology and hepatology, 1995
- Uneven Distribution of Microgranules in Divided Lansoprazole Tablets Journal of pediatric gastroenterology and nutrition, 2015
- The effects of oral doses of lansoprazole and omeprazole on gastric pH. Journal of clinical gastroenterology, 1997
- Pharmacokinetics of neratinib during coadministration with lansoprazole in healthy subjects British journal of clinical pharmacology, 2017
- Lansoprazole as a potent HDAC2 inhibitor for treatment of colorectal cancer: An in-silico analysis and experimental validation Computers in biology and medicine, 2023
